South Korea-based Samsung Biologics, a leading contract development and manufacturing organization (CDMO), has anno...
Australian cellular health company Longevity Life Sciences has entered into a multi-year strategic partnership with Mits...
What are Caidya’s major highlights for 2026 that will strengthen its presence in the global CRO market? And what a...
Novotech, a leading global biotech CRO and full-service clinical research organisation, has strengthened its established...
Apodex has launched TRACES, a benchmark designed to evaluate how artificial intelligence systems perform on open-ended s...
Happiest Health’s The Edge of Nutrition 2026 brought together nutrition experts, clinicians, researchers and welln...
It is estimated that by 2040 China-originated treatments will represent 35% of US FDA approvals. When marketing treatmen...
The global CDMO market is moving beyond the era when manufacturing capacity alone defined competitive ...
QIAGEN, a global provider of Sample to Insight solutions, has officially commenced a new distribution partnership with H...
As antibody-drug conjugates (ADCs) transition from a promising therapeutic modality to a cornerstone of precision oncolo...
As the pharmaceutical industry advances towards increasingly complex, poorly soluble drug candidates, formulation has ...
As advanced therapeutics move from scientific promise to commercial reality, the industry's focus is shifting be...
Japan-based startup Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, a colla...
As cell and gene therapies advance toward commercial reality, the industry's focus is rapidly shifting beyond manufactur...
SGS has acquired CMIC, INC., a specialised bioanalytical testing services provider based in Chicago, Illinois, strengthe...
Thermo Fisher Scientific Inc., the world leader in serving science, has expanded its suite of Thermo Scientific™ O...
The rise of advanced therapies is fundamentally reshaping the contract manufacturing landscape, pushing CDMOs to evolve ...
US-based Taimei Technology, a leading artificial intelligence (AI)-powered drug clinical development platform company, a...
US-based 5 Horizons Ventures and Australia's Biointelect have announced a strategic partnership and investment alliance ...
As biologics pipelines grow more complex and timelines tighten, early stage process decisions are becoming criti...
Expecto Health Science, a full-service Asia-Pacific Contract Research Organization (CRO), announced a strategic pa...
Lunit, a South Korea-based provider of artificial intelligence (AI) for cancer diagnostics and precision oncology, and C...
Australia-based Monash University and ClinChoice Inc, a leading global clinical Contract Research Organization (CRO) foc...
On the sidelines of the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectr...
At the APAC Biomanufacturing Leadership Summit 2026 in Singapore, organised by Charles River, BioSpectrum Asia spoke wit...
